Skip to main content
Top
Published in: Pediatric Rheumatology 1/2013

Open Access 01-11-2013 | Meeting abstract

PW01-012 – Canakinumab in patients with FMF

Authors: S Ugurlu, E Seyahi, G Hatemi, A Hacioglu, H Ozdogan

Published in: Pediatric Rheumatology | Special Issue 1/2013

Login to get access

Excerpt

In a recent pilot study, it was reported that Canakinumab reduced the frequency of attacks in 9 patients with Familial Mediterranean Fever (FMF) resistant to colchicine with no apparent side effects [1]. …
Literature
1.
go back to reference Gul A, Ozdogan H, Erer B, Ugurlu S, Davis N, Sevgi S, Kasapcopur O: Efficacy and Safety of Canakinumab in Adults with Colchicine Resistant Familial Mediterranean Fever. Arthritis Rheum. 2013, 64 (10): S322- Gul A, Ozdogan H, Erer B, Ugurlu S, Davis N, Sevgi S, Kasapcopur O: Efficacy and Safety of Canakinumab in Adults with Colchicine Resistant Familial Mediterranean Fever. Arthritis Rheum. 2013, 64 (10): S322-
Metadata
Title
PW01-012 – Canakinumab in patients with FMF
Authors
S Ugurlu
E Seyahi
G Hatemi
A Hacioglu
H Ozdogan
Publication date
01-11-2013
Publisher
BioMed Central
Published in
Pediatric Rheumatology / Issue Special Issue 1/2013
Electronic ISSN: 1546-0096
DOI
https://doi.org/10.1186/1546-0096-11-S1-A65

Other articles of this Special Issue 1/2013

Pediatric Rheumatology 1/2013 Go to the issue